Fried Robert N
- SEC CIK
- 0001417952
No open-market purchases or sales filed in the past year.
Current role at each company
- NAGE Niagen Bioscience, Inc.Chief Executive Officeras of Jul 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fried Robert N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 (view filing) | May 31 | 1 day | Fried Robert NChief Executive Officer | PPurchase | +7.00K | $1.42 | +$9.94K | +8.0%95.0K after | |
| Oct 3, 2022 (view filing) | Sep 30 | 3 days | Fried Robert NCheif Executive Officer | PPurchase | +80.0K | $1.25 | +$100.0K | +9.0%972.3K after | |
| Mar 16, 2022 (view filing) | Mar 16 | Same day | Fried Robert NCEO | PPurchase | +25.0K | $2.16 | +$54.0K | +39.7%88.0K after |